Last Price
5.90
Today's Change
-0.24 (3.90%)
Day's Change
5.82 - 6.27
Trading Volume
199,019
Market Cap
88 Million
Shares Outstanding
15 Million
Avg Volume
486,406
Avg Price (50 Days)
15.22
Avg Price (200 Days)
19.50
PE Ratio
-1.24
EPS
-4.75
Earnings Announcement
03-Mar-2025
Previous Close
6.14
Open
6.15
Day's Range
5.82 - 6.27
Year Range
5.25 - 31.01
Trading Volume
199,019
1 Day Change
-3.91%
5 Day Change
-7.52%
1 Month Change
-16.31%
3 Month Change
-75.95%
6 Month Change
-63.89%
Ytd Change
-72.02%
1 Year Change
-65.40%
3 Year Change
-87.20%
5 Year Change
-94.06%
10 Year Change
-93.99%
Max Change
-93.99%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.